Stay updated on Sorafenib with or without SBRT in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior government funding/operating status notice was removed; these site maintenance changes do not affect the study information, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T04:55:32.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Updated study plan sections add NIH-required analyses and core outcome definitions (overall survival by race/ethnicity/sex, time to progression, progression-free survival) and the follow-up schedule. A funding lapse notice and revised dates (2026-01-08, 2026-01-28) are now displayed.
    Difference
    0.8%
    Check dated 2026-02-04T03:46:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary toggle added for user assistance, and the page now includes QC-related update fields (Last Update Submitted that Met QC Criteria, Last Update Posted) with the site revision updated to v3.4.0 (from v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T00:45:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T00:36:00.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations section updated to a consolidated list of sites (California, Colorado, Connecticut, Florida, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Mississippi, Missouri, New Jersey, New York, Ohio, Oregon, Pennsylvania, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, Victoria, Alberta, Ontario, Quebec, Korea) with previous per-location entries removed; a new Revision: v3.3.3 tag is displayed.
    Difference
    2%
    Check dated 2025-12-23T07:42:34.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 supersedes v3.3.1; this is a metadata revision and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:42:25.000Z thumbnail image

Stay in the know with updates to Sorafenib with or without SBRT in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.